HRMY

Harmony Biosciences Holdings, Inc.

30.91 USD
+0.04 (+0.13%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Harmony Biosciences Holdings, Inc. stock is up 1.95% since 30 days ago. The next earnings date is Apr 30, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 March’s closed higher than February. In the last 1 Unusual Options Trades, there were 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
23 Feb 16:34 19 Apr, 2024 30.00 PUT 262 139

About Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc. develops and commercializes therapies for patients with rare neurological disorders in the United States. WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy.

  • Mizuho
    Tue Feb 27, 10:42
    buy
    confirm
  • Cantor Fitzgerald
    Fri Feb 23, 12:18
    buy
    confirm
  • Needham
    Fri Feb 23, 05:42
    buy
    confirm
  • Needham
    Thu Feb 22, 08:46
    buy
    confirm
  • Mizuho
    Fri Feb 16, 18:48
    buy
    confirm